[Form 4] Medtronic plc Insider Trading Activity
William R. Jellison, a director of Medtronic plc (MDT), reported two open-market purchases of ordinary shares. He acquired 2,500 shares on 08/22/2025 at $92.73 per share and 2,500 shares on 08/25/2025 at $92.37 per share, bringing his reported direct beneficial ownership to 5,000 shares. The filing notes the shares are held in a joint account with his spouse. The Form 4 was executed by an attorney-in-fact on 08/25/2025. No derivative transactions or dispositions are reported in this filing.
William R. Jellison, membro del consiglio di amministrazione di Medtronic plc (MDT), ha comunicato due acquisti in mercato aperto di azioni ordinarie. Ha acquistato 2.500 azioni il 22/08/2025 a 92,73$ l鈥檜na e 2.500 azioni il 25/08/2025 a 92,37$ l鈥檜na, portando la sua partecipazione diretta a 5.000 azioni. Il deposito indica che le azioni sono detenute in un conto cointestato con il coniuge. Il Modulo 4 猫 stato sottoscritto da un procuratore il 25/08/2025. Non sono riportate operazioni su derivati n茅 dismissioni in questo deposito.
William R. Jellison, director de Medtronic plc (MDT), inform贸 sobre dos compras en el mercado abierto de acciones ordinarias. Adquiri贸 2.500 acciones el 22/08/2025 a 92,73$ por acci贸n y 2.500 acciones el 25/08/2025 a 92,37$ por acci贸n, elevando su participaci贸n directa a 5.000 acciones. La presentaci贸n indica que las acciones se mantienen en una cuenta conjunta con su c贸nyuge. El Formulario 4 fue firmado por un apoderado el 25/08/2025. En esta presentaci贸n no se informan transacciones con derivados ni enajenaciones.
Medtronic plc(MDT) 鞚挫偓鞚� William R. Jellison鞚� 氤错喌欤茧ゼ 鞛ル偞 毵れ垬頃� 靷嫟鞚� 鞁犼碃頄堨姷雼堧嫟. 攴鸽姅 2025-08-22鞐� 欤茧嫻 $92.73鞐� 2,500欤茧ゼ, 2025-08-25鞐� 欤茧嫻 $92.37鞐� 2,500欤茧ゼ 毵れ垬頃橃棳 攴胳潣 歆侅爲鞝� 氤挫湢歆�攵勳潉 5,000欤�搿� 電橂牳鞀惦媹雼�. 鞝滌稖靹滊鞐愲姅 頃措嫻 欤检嫕鞚� 氚办毎鞛愳檧鞚� 瓿惦彊 瓿勳鞐� 氤搓磤霅橃柎 鞛堧嫟瓿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. Form 4電� 2025-08-25鞐� 雽�毽澑鞚� 靹滊獏頄堨姷雼堧嫟. 鞚� 鞝滌稖靹滊鞐愲姅 韺岇儩靸來拡 瓯半灅雮� 觳橂秳鞚� 氤搓碃霅橃 鞎婌晿鞀惦媹雼�.
William R. Jellison, administrateur de Medtronic plc (MDT), a d茅clar茅 deux achats d鈥檃ctions ordinaires sur le march茅 libre. Il a acquis 2 500 actions le 22/08/2025 脿 92,73$ l鈥檜nit茅 et 2 500 actions le 25/08/2025 脿 92,37$ l鈥檜nit茅, portant sa participation directe 脿 5 000 actions. Le d茅p么t pr茅cise que les actions sont d茅tenues sur un compte joint avec son conjoint. Le Formulaire 4 a 茅t茅 sign茅 par un mandataire le 25/08/2025. Aucune transaction sur d茅riv茅s ni cession n鈥檈st signal茅e dans ce d茅p么t.
William R. Jellison, Direktor von Medtronic plc (MDT), meldete zwei K盲ufe von Stammaktien am offenen Markt. Er erwarb am 22.08.2025 2.500 Aktien zu je 92,73$ und am 25.08.2025 2.500 Aktien zu je 92,37$, womit seine gemeldete direkte Beteiligung 5.000 Aktien betr盲gt. Die Einreichung vermerkt, dass die Aktien in einem Gemeinschaftskonto mit seiner Ehefrau gehalten werden. Das Formular 4 wurde am 25.08.2025 von einem Bevollm盲chtigten unterzeichnet. In dieser Einreichung sind keine Derivatgesch盲fte oder Ver盲u脽erungen gemeldet.
- Director purchased additional common stock, acquiring 5,000 shares in two transactions and increasing reported direct ownership
- Transactions are disclosed with explicit prices and dates, supporting transparency under Section 16 reporting requirements
- None.
Insights
TL;DR: Director made modest open-market purchases totaling 5,000 shares, indicating a routine insider buy.
These purchases are disclosed under Section 16 reporting rules and reflect direct acquisitions rather than derivative activity. The combined purchase amount (~$462,500) is a straightforward insider buy and does not by itself constitute a material change to ownership or control. The filing also documents joint holding with a spouse and was signed by an attorney-in-fact, which are standard procedural details. Governance implications are limited given the small size relative to a large-cap issuer.
TL;DR: Two purchase transactions at roughly $92.7 and $92.4 increased director's direct holdings to 5,000 shares.
From a market-data perspective this Form 4 reports routine, small-scale purchases by an insider. The transactions are recorded with explicit prices and dates, with no sales or option exercises. For investors tracking insider activity, this is factual confirmation of buy-side activity but lacks scale to signal a meaningful shift in insider conviction or ownership concentration.
William R. Jellison, membro del consiglio di amministrazione di Medtronic plc (MDT), ha comunicato due acquisti in mercato aperto di azioni ordinarie. Ha acquistato 2.500 azioni il 22/08/2025 a 92,73$ l鈥檜na e 2.500 azioni il 25/08/2025 a 92,37$ l鈥檜na, portando la sua partecipazione diretta a 5.000 azioni. Il deposito indica che le azioni sono detenute in un conto cointestato con il coniuge. Il Modulo 4 猫 stato sottoscritto da un procuratore il 25/08/2025. Non sono riportate operazioni su derivati n茅 dismissioni in questo deposito.
William R. Jellison, director de Medtronic plc (MDT), inform贸 sobre dos compras en el mercado abierto de acciones ordinarias. Adquiri贸 2.500 acciones el 22/08/2025 a 92,73$ por acci贸n y 2.500 acciones el 25/08/2025 a 92,37$ por acci贸n, elevando su participaci贸n directa a 5.000 acciones. La presentaci贸n indica que las acciones se mantienen en una cuenta conjunta con su c贸nyuge. El Formulario 4 fue firmado por un apoderado el 25/08/2025. En esta presentaci贸n no se informan transacciones con derivados ni enajenaciones.
Medtronic plc(MDT) 鞚挫偓鞚� William R. Jellison鞚� 氤错喌欤茧ゼ 鞛ル偞 毵れ垬頃� 靷嫟鞚� 鞁犼碃頄堨姷雼堧嫟. 攴鸽姅 2025-08-22鞐� 欤茧嫻 $92.73鞐� 2,500欤茧ゼ, 2025-08-25鞐� 欤茧嫻 $92.37鞐� 2,500欤茧ゼ 毵れ垬頃橃棳 攴胳潣 歆侅爲鞝� 氤挫湢歆�攵勳潉 5,000欤�搿� 電橂牳鞀惦媹雼�. 鞝滌稖靹滊鞐愲姅 頃措嫻 欤检嫕鞚� 氚办毎鞛愳檧鞚� 瓿惦彊 瓿勳鞐� 氤搓磤霅橃柎 鞛堧嫟瓿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. Form 4電� 2025-08-25鞐� 雽�毽澑鞚� 靹滊獏頄堨姷雼堧嫟. 鞚� 鞝滌稖靹滊鞐愲姅 韺岇儩靸來拡 瓯半灅雮� 觳橂秳鞚� 氤搓碃霅橃 鞎婌晿鞀惦媹雼�.
William R. Jellison, administrateur de Medtronic plc (MDT), a d茅clar茅 deux achats d鈥檃ctions ordinaires sur le march茅 libre. Il a acquis 2 500 actions le 22/08/2025 脿 92,73$ l鈥檜nit茅 et 2 500 actions le 25/08/2025 脿 92,37$ l鈥檜nit茅, portant sa participation directe 脿 5 000 actions. Le d茅p么t pr茅cise que les actions sont d茅tenues sur un compte joint avec son conjoint. Le Formulaire 4 a 茅t茅 sign茅 par un mandataire le 25/08/2025. Aucune transaction sur d茅riv茅s ni cession n鈥檈st signal茅e dans ce d茅p么t.
William R. Jellison, Direktor von Medtronic plc (MDT), meldete zwei K盲ufe von Stammaktien am offenen Markt. Er erwarb am 22.08.2025 2.500 Aktien zu je 92,73$ und am 25.08.2025 2.500 Aktien zu je 92,37$, womit seine gemeldete direkte Beteiligung 5.000 Aktien betr盲gt. Die Einreichung vermerkt, dass die Aktien in einem Gemeinschaftskonto mit seiner Ehefrau gehalten werden. Das Formular 4 wurde am 25.08.2025 von einem Bevollm盲chtigten unterzeichnet. In dieser Einreichung sind keine Derivatgesch盲fte oder Ver盲u脽erungen gemeldet.
FAQ
What trades did Medtronic director William R. Jellison report on Form 4 (MDT)?
How many shares does William R. Jellison own after the reported transactions?
Were any derivative securities or sales reported in this Form 4 for MDT?
Are the shares held directly or indirectly according to the filing?
Who signed the Form 4 and when was it executed?
